|1|The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms. (27458977)
Long L.M.... Liu Y.S.
|2|Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy. (27237099)
Ishida J.... Ku Y.
|3|Efficacy of contrast-enhanced harmonic endoscopic ultrasonography in the diagnosis of pancreatic ductal carcinoma. (27184637)
Uekitani T.... Sakaida I.
|4|Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma. (27552832)
Dugnani E.... Piemonti L.
|5|Alteration of strain ratio evaluated by transabdominal ultrasound elastography may predict the efficacy of preoperative chemoradiation performed for pancreatic ductal carcinoma: preliminary results. (24901166)
Kawada N.... Tomita Y.
|6|Preoperative platelet-lymphocyte ratio in resected pancreatic ductal carcinoma: is it meaningful? (20579970)
DomA-nguez I.... FernA!ndez-del Castillo C.
|7|Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue. (22892044)
Takadate T.... Unno M.
|8|Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model. (22190076)
Siddique H.R.... Saleem M.
|9|Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. (21841817)
Eppinga R.D.... McNiven M.A.
|10|Clinicopathologic assessment of pancreatic ductal carcinoma located at the head of the pancreas, in relation to embryonic development. (22228049)
Okamura Y.... Nakao A.
|11|Assessment of the interface between retroperitoneal fat infiltration of pancreatic ductal carcinoma and the major artery by multidetector-row computed tomography: surgical outcomes and correlation with histopathological extension. (22562451)
Yamamoto Y.... Hiraoka N.
|12|KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. (21224073)
Zammarchi F.... Mazzanti C.M.
|13|Asymptomatic curable pancreatic ductal carcinoma detected during the follow-up of pancreatic cysts distinct from carcinoma. (26190721)
Kawada N.... Ishikawa O.
|14|Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with I^-catenin in tumor progression. (21466814)
Xu H.... Kokudo N.
|15|Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma. (19020717)
Inami K.... Hino O.
|16|Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma. (18505086)
Pryczynicz A.... Czyzewska J.
|17|Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma. (17003643)
Shimada K.... Hiraoka N.
|18|Factors predicting recurrence after resection of pancreatic ductal carcinoma. (15968250)
Shibata K.... Kitano S.
|19|Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. (16335935)
Cecconi D.... Righetti P.G.
|20|Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. (16053509)
Ishikawa M.... Mano H.
|21|Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. (15548371)
GrA1tzmann R.... Saeger H.D.
|22|Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives. (14745573)
GrA1tzmann R.... Pilarsky C.
|23|Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma. (14707723)
Tepel J.... Kalthoff H.
|24|Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. (14973050)
MA1erkAPster S.... SchAofer H.
|25|A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. (15258755)
Monti P.... Piemonti L.
|26|A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. (12692724)
Sipos B.... KlAPppel G.
|27|Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. (12717266)
Kuwahara K.... Chayama K.
|28|MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. (14681945)
Chhieng D.C.... Manne U.
|29|Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. (12783462)
Cecconi D.... Righetti P.G.
|30|Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: an immunohistochemical study. (12650514)
Yamazaki K.... Ishida Y.
|31|Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. (12448000)
Sipos B.... KlAPppel G.
|32|Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma. (12429967)
Tobita K.... Makuuchi H.
|33|Endocrine and intermediate cells in pancreatic ductal carcinoma and in chronic pancreatitis. (12533945)
Szynaka B.... Szynaka P.
|34|Heterogeneic distribution of thymidine phosphorylase between primary tumors and metastatic lesions of human pancreatic ductal carcinoma: implications for the efficacy of chemotherapy with 5-FU or its derivatives. (11391857)
Minari Y.... Dong M.
|35|Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. (11238189)
Weddle D.L.... Schuller H.M.
|36|The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. (10861575)
LA1ttges J.... KlAPppel G.
|37|The molecular genetics of pancreatic ductal carcinoma: a review. (11356337)
Sohn T.A.... Yeo C.J.
|38|Centrosome abnormalities in pancreatic ductal carcinoma. (10353727)
Sato N.... Tanaka M.
|39|Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. (10076772)
Sessa F.... Capella C.
|40|Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. (9417916)
Biunno I.... Sgaramella V.
|41|p53 protein overexpression and K-ras codon 12 mutation in pancreatic ductal carcinoma: correlation with histologic factors. (9293533)
Kasuya K.... Koyanagi Y.
|42|Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. (9815776)
Suehara N.... Tanaka M.
|43|Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms. (8915489)
Franz M.G.... Gower W.R.
|44|Hematogenous metastases of pancreatic ductal carcinoma. (8532650)
Kamisawa T.... Okamoto A.
|45|Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. (8020665)
Bockman D.E.... Beger H.G.
|46|Sustained recovery from a solid type pancreatic ductal carcinoma originating in the pancreas tail: a case report. (8385066)
Furuta K.... Watanabe H.
|47|Pancreatic microcystic adenoma coexistent with pancreatic ductal carcinoma. A report of two cases. (2157344)
Montag A.G.... Michelassi F.
|48|Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. (2539915)
Egami H.... Pour P.M.
|49|Dilemma of pancreatic ductal carcinoma. (453140)
Weingarten L.... Fischer M.G.
|50|Early lesions of pancreatic ductal carcinoma in the hamster model. (195472)
Pour P.... Takahashi M.